AllianceBernstein
FLGT icon

AllianceBernstein’s Fulgent Genetics FLGT Stock Holding History

AllianceBernstein’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$301K Buy
18,961
+2,940
+18% +$49.8K ﹤0.01% 2985
2026
Q1 		$421K Sell
16,021
-2,436
-13% -$52.9K ﹤0.01% 2721
2025
Q4 		$485K Sell
18,457
-4,800
-21% -$125K ﹤0.01% 2670
2025
Q3 		$526K Hold
23,257
– – ﹤0.01% 2644
2025
Q2 		$462K Buy
23,257
+2,636
+13% +$51.4K ﹤0.01% 2687
2025
Q1 		$348K Hold
20,621
– – ﹤0.01% 2708
2024
Q4 		$381K Hold
20,621
– – ﹤0.01% 2762
2024
Q3 		$448K Hold
20,621
– – ﹤0.01% 2714
2024
Q2 		$405K Buy
20,621
+3,270
+19% +$68.3K ﹤0.01% 2781
2024
Q1 		$377K Sell
17,351
-2,600
-13% -$64.6K ﹤0.01% 2715
2023
Q4 		$577K Hold
19,951
– – ﹤0.01% 2538
2023
Q3 		$533K Buy
19,951
+51
+0.3% +$1.74K ﹤0.01% 2540
2023
Q2 		$737K Hold
19,900
– – ﹤0.01% 2446
2023
Q1 		$621K Sell
19,900
-5,221
-21% -$168K ﹤0.01% 2451
2022
Q4 		$748K Sell
25,121
-64
-0.3% -$2.29K ﹤0.01% 2425
2022
Q3 		$960K Buy
25,185
+106
+0.4% +$5.31K ﹤0.01% 2307
2022
Q2 		$1.37M Buy
25,079
+73
+0.3% +$4.01K ﹤0.01% 2172
2022
Q1 		$1.56M Buy
25,006
+131
+0.5% +$8.63K ﹤0.01% 2229
2021
Q4 		$2.5M Buy
24,875
+41
+0.2% +$3.6K ﹤0.01% 2008
2021
Q3 		$2.23M Sell
24,834
-6,610
-21% -$601K ﹤0.01% 2104
2021
Q2 		$2.9M Buy
31,444
+9,310
+42% +$743K ﹤0.01% 1953
2021
Q1 		$2.14M Buy
22,134
+9,620
+77% +$993K ﹤0.01% 2071
2020
Q4 		$652K Hold
12,514
– – ﹤0.01% 2478
2020
Q3 		$501K Sell
12,514
-6,186
-33% -$194K ﹤0.01% 2528
2020
Q2 		$299K Buy
+18,700
New +$286K ﹤0.01% 2874

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein's FLGT Position: Q2 2026 in Review

AllianceBernstein increased its Fulgent Genetics (FLGT) stake by 18% in Q2 2026, buying an estimated $49.8K and bringing the position to 18,961 shares worth $301K. The position accounts for ﹤0.01% of the portfolio, ranked #2985.

AllianceBernstein first reported a position in FLGT in Q2 2020 and has held it in 25 quarters since. The position peaked at $2.9M in Q2 2021. 142 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • AllianceBernstein held 18,961 shares of Fulgent Genetics worth $301K as of Q2 2026.
  • AllianceBernstein bought 2,940 Fulgent Genetics shares in Q2 2026, an estimated $49.8K.
  • Fulgent Genetics made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #2985 holding.
  • AllianceBernstein first reported a position in Fulgent Genetics in Q2 2020 and has held it in 25 quarters since.
  • AllianceBernstein's Fulgent Genetics position peaked at $2.9M in Q2 2021.
  • 142 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.